TetraLogic Pharmaceuticals is a clinical-stage biopharmaceutical company focused on discovering, acquiring and developing novel product candidates to treat cancer and infectious diseases
TetraLogic Pharmaceuticals is a clinical-stage biopharmaceutical company focused on discovering, acquiring and developing novel product candidates to treat cancer and infectious diseases. It currently has two clinical-stage product candidates in development: birinapant and suberohydroxamic acid (SHAPE).